Mostrar o rexistro simple do ítem

Tumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non-Hodgkin's lymphoma

dc.contributor.authorPérez Encinas, Manuel Mateo 
dc.contributor.authorVillamayor Álvarez, Mercedes 
dc.contributor.authorCampos Pena, Alfredo 
dc.contributor.authorGonzález Pérez, Marta Sonia 
dc.contributor.authorBello López, José Luis 
dc.date.accessioned2026-01-27T11:02:27Z
dc.date.available2026-01-27T11:02:27Z
dc.date.issued1998
dc.identifier.issn0390-6078
dc.identifier.otherhttps://pubmed.ncbi.nlm.nih.gov/9793264/es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/22542
dc.description.abstract[EN] We studied the value of soluble CD25, CD8, CD23, CD54 and CD44 serum levels as tumor burden markers in lymphoma. Soluble CD25 compared with the others sCD and the usual serum factors (albumin, lactate dehydrogenase, beta 2-microglobulin, uric acid and C-reactive protein), showed the strongest correlation with the Ann Arbor stage and the number of affected localizations. sCD25 level is the most sensitive serum marker for tumor burden in lymphoma.es
dc.language.isoenges
dc.rightsAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.meshPrognosis *
dc.subject.meshLymphoma *
dc.subject.meshAntigens, CD *
dc.subject.meshIntercellular Adhesion Molecule-1 *
dc.subject.meshLymphoma, Non-Hodgkin *
dc.subject.meshReceptors, Interleukin-2 *
dc.subject.meshSensitivity and Specificity *
dc.subject.meshReceptors, IgE *
dc.titleTumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non-Hodgkin's lymphomaes
dc.typeArtigoes
dc.bbddEmbase*
dc.bbddWOK*
dc.identifier.pmid9793264
dc.issue.number8es
dc.journal.titleHaematologicaes
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.)::Área Sanitaria de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Hematoloxía clínicaes
dc.page.initial752es
dc.page.final754es
dc.relation.publisherversionhttps://haematologica.org/article/view/1176es
dc.rights.accessRightsopenAccesses
dc.subject.cie10Linfoma de células B, sin otra especificación es
dc.subject.decspronóstico *
dc.subject.decslinfoma *
dc.subject.decssensibilidad y especificidad *
dc.subject.decslinfoma no Hodgkin *
dc.subject.decsreceptores de IgE *
dc.subject.decsmolécula 1 de adhesión intercelular *
dc.subject.decsantígenos CD *
dc.subject.decsreceptores de interleucina-2 *
dc.subject.keywordCHUSes
dc.typefidesArtigo de Opinión (Editorial, Carta, ...)es
dc.typesophosArtículo de Opiniónes
dc.volume.number83es


Ficheiros no ítem

Descargar/
Nome:
Haematologica. 1998 Aug;83(8)752-4.pdf
Tamaño:
126.4Kb
Formato:
PDF
Descrición:
Haematologica. 1998 Aug;83(8):752-4

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)